DECAUDenali Capital Acquisition Corp - Units (1 Ord Class A & 1 War)

$0.00
$0.00
(0.00%)
Today
Updated:
Mkt Cap$33.98M
Vol167.00

About

Semnur Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company focused on developing and commercializing innovative non-opioid pain management products for the treatment of acute and chronic pain. Its lead product candidate, SP-102, is a non-opioid novel injectable corticosteroid gel formulation for patients with moderate to severe lumbosacral radicular pain. The company is headquartered in Palo Alto, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
3

Frequently Asked Questions

What is Market Cap of Semnur Pharmaceuticals Inc - Units (1 Ord Class A & 1 War)?
What is the 52-week high for Semnur Pharmaceuticals Inc - Units (1 Ord Class A & 1 War)?
What is the 52-week low for Semnur Pharmaceuticals Inc - Units (1 Ord Class A & 1 War)?
What is Semnur Pharmaceuticals Inc - Units (1 Ord Class A & 1 War) stock price today?
What was Semnur Pharmaceuticals Inc - Units (1 Ord Class A & 1 War) stock price yesterday?
What is the PE ratio of Semnur Pharmaceuticals Inc - Units (1 Ord Class A & 1 War)?
What is the Price-to-Book ratio of Semnur Pharmaceuticals Inc - Units (1 Ord Class A & 1 War)?
What is the 50-day moving average of Semnur Pharmaceuticals Inc - Units (1 Ord Class A & 1 War)?
How many employees does Semnur Pharmaceuticals Inc - Units (1 Ord Class A & 1 War) have?

Latest DECAU News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.